Portal Instruments is developing a needle-free drug delivery technology designed to improve the administration of highly-viscous biologic drugs.
Companies have long sought after a needle-free injection platform as a solution to the anxiety people harbor about giving themselves shots. First-generation devices, according to Portal Instruments, all had the same problem: the jet was uncontrolled, leading to a sharp pain at the beginning of the injection and delivery challenges for high-volume drugs.
Portal’s product, which the company in-licensed from MIT, administers the injection in a stream the size of a strand of hair, using precise pressure technology to control the jet.
The company landed an exclusive $100 million deal with Takeda in November last year to combine Portal’s needle-free drug-delivery device with the pharmaceutical company’s biologic medicines.”
–Sarah Faulkner, Associate Editor